Press Releases

Press Releases

or

October 15, 2013
BeiGene, a biotechnology company focused on the discovery and development of innovative oncology treatments, has extended its collaboration with 3D BioOptima Co., Ltd., a leading global DMPK/PK-PD service provider. The two companies will continue to team up to a deeper and broader extent in drug
September 9, 2013
Hong Kong – Red Herring announced its Top 100 award in recognition of the leading private companies from Asia, celebrating these startups’ innovations and technologies across their respective industries. Red Herring’s Top 100 Asia list has become a mark of distinction for identifying promising new
September 3, 2013
Beijing – September 3, 2013 – BeiGene announced today it has been selected as a finalist for Red Herring’s Top 100 Asia award, a prestigious list honoring the year’s most promising private technology ventures from the Asian business region. The Red Herring editorial team selected the most
August 20, 2013
Beijing, China — August 20, 2013 — BeiGene, a leading Chinese oncology R&D company focused on discovering and developing novel, globally best-in-class drugs, today announced the appointment to its Scientific Advisory Board (SAB) of Neal Rosen, Charles Sawyers, David Schenkein, Xiaodong Wang, and
August 1, 2013
(Aug 1, 2013, Beijing) – BeiGene, a biotechnology company focused on the discovery and development of innovative oncology treatment, announced collaboration with GENEWIZ, Inc., leading global genomics service provider. The two companies will work together to accelerate cancer biomarker discovery,
August 1, 2013
BPBC (Beijing Pharma and Biotech Center) deputy director Li Qiong has visited BeiGene to hear the report made by R & D team about working projects of this company. After the meeting, Li Qiong gave a high praise to the work of BeiGene. About BPBC BPBC was established in June 24, 1996, it aimed to